Esin, E; Oksuzoglu, B; Bilici, A; Cicin, I; Kostek, O; Kaplan, MA; Aksoy, S; Aktas, BY; Ozdemir, O; Alacacioglu, A; Cabuk, D; Sumbul, AT; Sakin, A; Paydas, S; Yetisir, E; Er, O; Korkmaz, T; Yildirim, N; Sakalar, T; Demir, H; Artac, M; Karaagac, M; Harputluoglu, H; Bilen, E; Erdur, E; Degirmencioglu, S; Aliyev, A; Cil, T; Olgun, P; Basaran, G; Gumusay, O; Demir, A; Tanrikulu, E; Yumuk, PF; Imamoglu, I; Oyan, B; Cetin, B; Haksoyler, V; Karadurmus, N; Erturk, I; Evrensel, T; Yilmaz, H; Beypinar, I; Kocer, M; Pilanci, KN; Seker, M; Urun, Y; Eren, T; Demirci, U
(2019)
PurposeIn this study, we aimed to describe the real-life practice outcomes of pertuzumab-trastuzumab-taxane (PTT) combination in visceral organ metastatic, trastuzumab-naive breast cancer (BC) patients.MethodsThis study ...